Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHelios Underw Regulatory News (HUW)

Share Price Information for Helios Underw (HUW)

Share Price is delayed by 15 minutes
Get Live Data
214.50    -8.00 (-3.60%)
Bid:
211.00
Ask:
218.00
Spread: 7.00 (3.318%)
Market Cap: £146.53m
HUW Live PriceLast checked at - London Stock Exchange

Intraday Helios Underw Share Chart

Director Appointments

21 Oct 2025 07:01

RNS Number : 1127E
Helios Underwriting Plc
21 October 2025
 

21 October 2025

 

Helios Underwriting plc

("Helios" or the "Company")

 

Director Appointments

 

Helios Underwriting plc, the only publicly traded company offering instant access to a diverse portfolio of syndicates at Lloyd's of London, is pleased to confirm the appointment of Louis Tucker as CEO alongside the appointment of Joanna Parsons as an Independent Non-Executive Director of the Company.  Following Mr. Tucker's appointment, John Chambers will move to become Non-Executive Chairman of the Company.

 

CEO Appointment

Louis Tucker brings over two decades of experience across the Lloyd's Market, including a number of management level roles. He joins Helios from Arch Capital Group. In his role as Managing Director of Arch Managing Agency Ltd he was, amongst other things, responsible for managing the Lloyd's relationship and raising third-party capital.

Louis also has a strong track record managing and scaling businesses including Barbican Insurance Group which, alongside the two co-founders David Reeves and Mark Harrington, he helped establish in 2007. Together with his strong investor relations experience, Louis is an excellent fit to lead Helios at this exciting inflection point. 

 

Independent Non-Executive Director Appointment

Joanna Parsons joins Helios with over 25 years of experience spanning strategic and equity analysis, M&A, capital raising, ESG, and financial oversight within regulated environments. As Strategic Growth Leader for Capital Advisory at Aon UK, she advises multinational and Lloyd's syndicate clients. Her prior roles include leadership positions at Canaccord Genuity, ABN AMRO, RBS, and HSBC, complementing her broad experience in insurance and financials.

 

For further information, please contact:

 

Helios Underwriting plc

Louis Tucker - Chief Executive Officer

Tel: +44 (0)203 965 6441 

 

Adhiraj Maitra - Director of Finance and Operations

Tel: +44 (0) 203 743 2114

 

Deutsche Numis (Nomad and Broker)

Giles Rolls / Charles Farquhar

Tel: +44 (0)20 7601 6100

FTI Consulting

Ed Berry

Tel: +44 (0)7703 330 199

 

Christian Harte

Tel: +44 (0)7974 288 763

 

About Helios

Helios provides a limited liability direct investment into the Lloyd's insurance market and is quoted on the London Stock Exchange's AIM market (ticker: HUW). Helios trades within the Lloyd's insurance market. The portfolio provides a broad spread of business primarily participating in the US and other international wholesale and reinsurance markets. For further information please visit www.huwplc.com.

 

AIM Rule 17 - Louis Tucker

The following disclosures are made in accordance with Schedule 2(g) of the AIM Rules for Companies:

Louis Georg de Normanville Tucker, aged 52, and persons closely associated with him hold 44 ordinary shares in Helios Underwriting plc. Louis current and previous directorships are as follows:

 Current Partnerships / Directorships

Previous Partnerships / Directorships (last 5 years)

Marden's Club Ltd

Regents Bridge Gardens Ltd

Hindringham Design Ltd

 

Arch Corporate Member Ltd

Arch Corporate Member (No.3) Ltd

Arch Corporate Member (No.4) Ltd

Arch Corporate Member (No.6) Ltd

Arch Corporate Member (No.7) Ltd

Arch Corporate Member (No.10) Ltd

Arch Corporate Member (No.11) Ltd

Arch Corporate Member (No.12) Ltd

Arch Corporate Member (No.14) Ltd

Arch Corporate Member (No.16) Ltd

Arch Corporate Member (No.17) Ltd

Arch Corporate Member (No.18) Ltd

Arch Corporate Member (No.19) Ltd

Arch Syndicate Investments Ltd

Greenlight Re Corporate Member Ltd

London Bridge Corporate Member No.1 Ltd

Save as disclosed above, there are no further disclosures to be made in accordance with Rule 17 or Schedule 2(g) of the AIM Rules for Companies.

AIM Rule 17 - Joanna Parsons

The following disclosures are made in accordance with Schedule 2(g) of the AIM Rules for Companies:

Joanna Tamar Parsons (nee Francis), aged 61, holds nil ordinary shares in Helios Underwriting plc. Joanna's current and previous directorships are as follows:

 Current Partnerships / Directorships

Previous Partnerships / Directorships (last 5 years)

Ninety Cambridge Street Company Ltd

 

Claypole Partners Ltd

Save as disclosed above, there are no further disclosures to be made in accordance with Rule 17 or Schedule 2(g) of the AIM Rules for Companies.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAMMBLTMTBTBTA
Date   Source Headline
1st Jun 20267:00 amRNSTotal Voting Rights
1st Jun 20267:00 amRNSTransaction in Own Shares
27th May 20267:00 amRNSNotice of AGM
26th May 20267:00 amRNSTransaction in Own Shares
21st May 20267:00 amRNSFinal Results for the year ended 31 December 2025
18th May 20267:00 amRNSTransaction in Own Shares
14th May 20267:00 amRNSTR-1 announcement
11th May 20267:00 amRNSTransaction in Own Shares
5th May 20267:00 amRNSTransaction in Own Shares
1st May 20267:00 amRNSTotal Voting Rights
27th Apr 20267:00 amRNSTransaction in Own Shares
22nd Apr 20267:00 amRNSTR-1: Acquisition of Voting Rights
21st Apr 20267:00 amRNSChange of Nominated Adviser
20th Apr 20267:00 amRNSTransaction in Own Shares
14th Apr 20265:17 pmRNSHolding(s) in Company
10th Apr 20267:00 amRNSDirector/PDMR Shareholding
9th Apr 20267:00 amRNSQuarterly Syndicate Mid-point Forecast update
20th Jan 20267:00 amRNS2026 YOA Portfolio Update
9th Jan 20267:00 amRNSAppointment of Chief Underwriting Officer
4th Dec 20255:42 pmRNSGrant of LTIP Awards
2nd Dec 20257:00 amRNSNet Asset Value(s)
13th Nov 20251:32 pmRNSDirector/PDMR Shareholding
13th Nov 20251:30 pmRNSDirector/PDMR Shareholding
7th Nov 202510:10 amRNSHolding(s) in Company
6th Nov 20251:51 pmRNSDirector/PDMR Shareholding
5th Nov 20255:48 pmRNSTR1 - Change in breakdown of voting rights
30th Oct 20257:00 amRNSResult of Tender Offer
24th Oct 202512:20 pmRNSResults of General Meeting
21st Oct 20257:01 amRNSDirector Appointments
21st Oct 20257:00 amRNSCapital Markets Day
29th Sep 20257:01 amRNSProposed Tender Offer and Notice of GM
29th Sep 20257:00 amRNSHalf Year Results
19th Sep 20257:00 amRNSAppointment of Chief Executive Officer
1st Sep 20253:37 pmRNSDirector/PDMR Shareholding
29th Aug 202512:52 pmRNSPDMR Dealing
28th Aug 20252:16 pmRNSDirector/PDMR Shareholding
26th Aug 20257:00 amRNSQuarterly Syndicate Mid-point Forecasts
1st Aug 20257:00 amRNSTotal Voting Rights
31st Jul 202512:12 pmRNSTR-1: Notification of major holdings
18th Jul 20257:00 amRNSResults of Scrip Dividend Election
9th Jul 20259:45 amRNSResults of Scrip Dividend Election
30th Jun 20255:40 pmRNSAppointment of Executive Director
30th Jun 202512:28 pmRNSResult of AGM
30th Jun 20257:00 amRNSChange of Nominated Adviser
20th Jun 20259:32 amRNSScrip Dividend Reference Price
9th Jun 20251:15 pmRNSLTIP Exercise and Total Voting Rights Update
9th Jun 20251:15 pmRNSGrant of LTIP Awards
2nd Jun 20257:00 amRNSPosting of Annual Report and Notice of AGM
2nd Jun 20257:00 amRNSFinal results for the year ended 31 December 2024
29th May 20257:06 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.